| Date Filed | Type | Description |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| Sharp John P (CFO) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 2,017 shares
@ $2.01, valued at
$4.1k
|
|
| 11/03/2021 |
4
| Sharp John P (CFO) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Exercised 7,500 options to buy
@ $1.68, valued at
$12.6k
|
|
| 09/03/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/04/2021 |
4
| Sharp John P (CFO) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 7,500 shares
@ $1.68, valued at
$12.6k
|
|
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2020 |
4
| Sharp John P (CFO) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 1,305 shares
@ $3, valued at
$3.9k
|
|
| 08/17/2020 |
4
| Sharp John P (CFO) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Exercised 5,000 options to buy
@ $1.69, valued at
$8.5k
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/22/2019 |
4
| Sharp John P (CFO and Secretary) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Exercised 10,000 options to buy
@ $1.69, valued at
$16.9k
Exercised 5,000 options to buy
@ $1.44, valued at
$7.2k
|
|
| 05/24/2019 |
4
| Sharp John P (CFO and Secretary) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Exercised 15,000 options to buy
@ $1.69, valued at
$25.4k
|
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2018 |
4
| Sharp John P (CFO and Secretary) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Bought 5,000 shares
@ $3.84, valued at
$19.2k
|
|
| 10/17/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/14/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2013 |
4
| Sharp John P (VP Finance and CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 700 shares
@ $53.44, valued at
$37.4k
Exercised 700 options to buy
@ $9.96, valued at
$7k
|
|
| 12/09/2013 |
4
| Sharp John P (VP Finance and CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 6,000 shares
@ $56.08, valued at
$336.5k
|
|
| 11/20/2013 |
4
| Sharp John P (VP Finance and CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 1,123 shares
@ $53, valued at
$59.5k
Exercised 624 options to buy
@ $9.96, valued at
$6.2k
|
|
| 08/20/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/19/2013 |
4
| Sharp John P (VP Finance and CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 4,432 options to buy
@ $21.92, valued at
$97.1k
Granted 15,568 options to buy
@ $21.92, valued at
$341.3k
|
|
| 02/18/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2010 |
4
| Sharp John P (VP Finance and CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 6,000 shares
@ $0
Granted 18,000 shares
@ $0
Granted 100,000 options to buy
@ $1.66, valued at
$166k
|
|
| 01/28/2010 |
4
| Sharp John P (VP Finance and CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 6,000 options to buy
@ $2.69, valued at
$16.1k
|
|